98%
921
2 minutes
20
Background: Patients with polycystic ovary syndrome (PCOS) face a greater risk of miscarriage during pregnancy. However, the relationship between PCOS and missed abortion (MA) has not been comprehensively studied.
Method: This retrospective study included 194 pregnant women with PCOS, diagnosed using the 2004 Rotterdam criteria. Participants were categorized into the MA group (n = 100) or the control group (term live births, n = 94) based on pregnancy outcomes. Baseline characteristics and clinical features were collected, and statistical analyses were performed to identify MA risk factors.
Results: At baseline, the MA group had a lower BMI (p = 0.000) and higher educational level (p = 0.026) compared to the control group, with no significant differences in other baseline characteristics. Regarding clinical features, significant differences were observed in conception method, menstrual period duration, menstrual patterns, total testosterone, fasting insulin, and anti-Müllerian hormone (AMH) levels. After adjusting for BMI and educational level, univariate analysis identified oligomenorrhea (OR = 10.502, p = 0.000), menstrual period duration (OR = 1.888, p = 0.002), total testosterone (OR = 1.047, p = 0.009), and AMH (OR = 1.286, p = 0.044) as significant risk factors. Multivariate logistic regression confirmed that menstrual period duration (OR = 2.074, p = 0.003), oligomenorrhea (OR = 12.487, p < 0.001), and total testosterone (OR = 1.067, p = 0.003) were independently associated with MA risk in PCOS patients.
Conclusion: This study identifies menstrual period duration, oligomenorrhea, and total testosterone as independent risk factors for MA in women with PCOS. These findings highlight the importance of monitoring menstrual irregularities and hormonal profiles to optimize pregnancy outcomes in PCOS patients.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12341064 | PMC |
http://dx.doi.org/10.1186/s12884-025-07975-5 | DOI Listing |
Yakugaku Zasshi
September 2025
Kampo Research Laboratories, Pharmaceutical Company, Kracie, Ltd.
Dysmenorrhea refers to pathological symptoms that occur in association with menstruation during the menstrual period. Treatment options for dysmenorrhea include nonsteroidal anti-inflammatory drugs (NSAIDs) and low-dose estrogen-progestin combination pills. However, some patients do not respond to these treatments, and long-term use can lead to adverse reactions, raising additional problems.
View Article and Find Full Text PDFHum Reprod Update
September 2025
Women's Health Research Collaborative, New York, NY, USA.
Background: Reproductive-age women with intrauterine adhesions (IUAs) following uterine surgery may be asymptomatic or may experience light or absent menstruation, infertility, preterm delivery, and/or peripartum hemorrhage. Understanding procedure- and technique-specific risks and the available evidence on the impact of surgical adjuvants is essential to the design of future research.
Objective And Rationale: While many systematic reviews have been published, most deal with singular aspects of the problem.
Contraception
September 2025
Bayer Aktiengesellschaft, Wuppertal - Aprath, Germany.
Objective: This study aimed to validate the real-world performance of the MyIUS mobile-application algorithm in predicting bleeding intensity and regularity in levonorgestrel intrauterine device (LNG-IUD) 52 mg, 19.5 mg, and 13.5 mg users following device insertion.
View Article and Find Full Text PDFPLoS One
September 2025
Key Laboratory of Environmental Medicine and Engineering of Ministry of Education, Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing, Jiangsu, China.
Objective: This study aimed to investigate the relationship between women's fecundability and postpartum breastfeeding.
Methods: We used a prospective cohort study design to recruit pregnant women who came to the hospital for antenatal checkups before 20 weeks' gestation between April 2019 and March 2020 at the Maternal and Child Health Hospital of Gulou District, Nanjing, China. Women were categorized into prolonged time to pregnancy (TTP) group (>3 months) and shorten TTP (≤3 months) groups.